| (Values in U.S. Thousands) | Sep, 2016 | Sep, 2015 | Sep, 2014 | Sep, 2013 | Sep, 2012 |
| Sales | 22,120 | 32,600 | 24,490 | 31,450 | 35,030 |
| Sales Growth | -32.15% | +33.12% | -22.13% | -10.22% | unch |
| Net Income | 340 | 4,340 | 2,430 | 14,340 | 15,290 |
| Net Income Growth | -92.17% | +78.60% | -83.05% | -6.21% | unch |
Female Health Co (FHCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
The Female Health Company manufactures, markets and sells the Female Condom, the only FDA-approved product under a woman's control which can prevent unintended pregnancy and sexually transmitted diseases, including HIV/AIDS. It is the only HIV/AIDS product specifically developed and approved by regulatory agencies in the U.S., the European Union, Japan and The People's Republic of China, among others, since the epidemic beganabout twenty years ago for the prevention of the transmission of HIV/AIDS through sexual contact.